Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections
ACS Central Science · 27.12.2023 · 9 (12) · 2205-2215
DOI: 10.1021/acscentsci.3c01102 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Central Science, online erschienen am 27.10.2023. Verfasst von Jelena Konstantinović und 20 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Saarbrücken 66123, Germany. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium f?r Bildung und Forschung, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, Austrian Science Fund.
Abstract (Originalsprache)
Infections caused by the Gram-negative pathogen Pseudomonas aeruginosa are emerging worldwide as a major threat to human health. Conventional antibiotic monotherapy suffers from rapid resistance development, underlining urgent need for novel treatment concepts. Here, we report on a nontraditional approach to combat P. aeruginosa-derived infections by targeting its main virulence factor, the elastase LasB. We discovered a new chemical class of phosphonates with an outstanding in vitro ADMET and PK profile, auspicious activity both in vitro and in vivo. We established the mode of action through a cocrystal structure of our lead compound with LasB and in several in vitro and ex vivo models. The proof of concept of a combination of our pathoblocker with levofloxacin in a murine neutropenic lung infection model and the reduction of LasB protein levels in blood as a proof of target engagement demonstrate the great potential for use as an adjunctive treatment of lung infections in humans.
Autor:innen und Institutionen
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)-Helmholtz Centre for Infection Research (HZI), Saarbrücken 66123, Germany.
- Department of Chemistry of Natural and Microbial Products, Institute of Pharmaceutical and Drug Industries Research, National Research Centre, El-Buhouth Street, Dokki, Cairo 12622, Egypt.
- Department of Pharmacy, Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken 66123, Germany.
- Department of Internal Medicine V - Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg 66421, Germany.
- Saarland University, Department of Pharmacy, Saarbrücken 66123, Germany.
- Department of Biosciences and Medical Biology, Division of Structural Biology, University of Salzburg, Salzburg 5020, Austria.
ORCID-Profile: Andreas M Kany, Ahmed S Abdelsamie, Katrin Voos, Rolf W Hartmann, Christian Ducho, Anna K H Hirsch
Förderung
- Bundesministerium f?r Bildung und Forschung
- Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator
- Austrian Science Fund
- Alexander von Humboldt-Stiftung
- Helmholtz Association
- H2020 European Research Council
Zitieren
APA
Konstantinović, J., Kany, A. M., Alhayek, A., Abdelsamie, A. S., Sikandar, A., Voos, K., Yao, Y., Andreas, A., Shafiei, R., Loretz, B., Schönauer, E., Bals, R., Brandstetter, H., Hartmann, R. W., Ducho, C., Lehr, C. M., Beisswenger, C., Müller, R., Rox, K., …, & Hirsch, A. K. H. (2023). Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections. ACS Central Science, 9(12), 2205-2215. https://doi.org/10.1021/acscentsci.3c01102
Vancouver
Konstantinović J, Kany AM, Alhayek A, Abdelsamie AS, Sikandar A, Voos K, et al. Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections. ACS Central Science. 2023;9(12):2205-2215. doi:10.1021/acscentsci.3c01102
BibTeX
@article{Konstantinovi2023,
author = {Konstantinović, Jelena and Kany, Andreas M and Alhayek, Alaa and Abdelsamie, Ahmed S and Sikandar, Asfandyar and Voos, Katrin and Yao, Yiwen and Andreas, Anastasia and Shafiei, Roya and Loretz, Brigitta and Schönauer, Esther and Bals, Robert and Brandstetter, Hans and Hartmann, Rolf W and Ducho, Christian and Lehr, Claus-Michael and Beisswenger, Christoph and Müller, Rolf and Rox, Katharina and Haupenthal, Jörg and Hirsch, Anna K H},
title = {Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections},
journal = {ACS Central Science},
year = {2023},
volume = {9},
number = {12},
pages = {2205--2215},
doi = {10.1021/acscentsci.3c01102}
}
EUVIMED